PVCT   $0.0571  14.89% Market Closed

PROVECTUS BIOPHARMS
Total Cash 29.58K
totalCashPerShare 0.0
EBITDA -2.05M
Total Debt 3.05M
quickRatio 0.004
currentRatio 0.096
Total Revenue 683.91K
debtToEquity
Revenue/Share 0.002
ROA -1.01201
ROE
grossProfits
freeCashflow -1.61M
operatingCashflow -3.14M
earningsGrowth
revenueGrowth 0.576
grossMargins -1.56179
ebitdaMargins -2.99738
operatingMargins -2.54477
profitMargins 0.0
enterpriseValue 48.93M
forwardPE
floatShares 386.31M
sharesOutstanding 419.91M
sharesShort 1.82M
sharesShortPriorMonth 2.86M
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.08%
heldPercentInstitutions 0.00%
Short Ratio help_outline 0.47%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue -0.018
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -2.79M
trailingEps -0.01%
forwardEps
enterpriseToEbitda -23.87
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 7
lastUpdated Nov. 6, 2024, 6:25 p.m.